<p>Percentage of relapsing mice and bacterial burden in mice vaccinated SC or IN with MVATG18598 or empty vector, MVATGN33.1, during or after antibiotic regimen.</p
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VA...
<p>Mice were vaccinated and challenged as described in <a href="http://www.plosone.org/article/info:...
<p>Percentage of relapsing mice and bacterial burden in mice vaccinated SC with MVATG18598 during an...
<p>Percentage of relapsing mice and bacterial burden in mice vaccinated SC with increasing vaccinati...
After treatment with one of the control or test combination regimens depicted in Fig 1, both footpad...
<p>(A) The average fold change in 16 s rDNA copies was quantified by qPCR from stool of wildtype mic...
<p>Viral loads were determined by plaque assay from BALB/c mice 8 days postexposure (p.e.) following...
<p>Percent survival of mice treated with PBS or ribavirin and infected SC or by aerosol with RVFV (n...
<p>Bacterial loads in the faeces of mice where quantified on days 1, 3 and 7, then weekly for 12 wee...
<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or ...
<p>Live vaccine but not killed vaccine controls bacterial loads following secondary challenge. Bacte...
<p>Ranking of efficacy on a range from − to +++ was based on weight loss and nasal colonization of m...
<p>Groups of mice co-treated with antibiotics (ATB) and MVATG18598 or MVATGN33.1 given thrice subcut...
<p>Number of relapsing mice (out of 6 infected) and day post-infection that relapses were observed a...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VA...
<p>Mice were vaccinated and challenged as described in <a href="http://www.plosone.org/article/info:...
<p>Percentage of relapsing mice and bacterial burden in mice vaccinated SC with MVATG18598 during an...
<p>Percentage of relapsing mice and bacterial burden in mice vaccinated SC with increasing vaccinati...
After treatment with one of the control or test combination regimens depicted in Fig 1, both footpad...
<p>(A) The average fold change in 16 s rDNA copies was quantified by qPCR from stool of wildtype mic...
<p>Viral loads were determined by plaque assay from BALB/c mice 8 days postexposure (p.e.) following...
<p>Percent survival of mice treated with PBS or ribavirin and infected SC or by aerosol with RVFV (n...
<p>Bacterial loads in the faeces of mice where quantified on days 1, 3 and 7, then weekly for 12 wee...
<p>Groups of ten BALB/c mice (3-week-old) were vaccinated with 5×10<sup>4</sup> PFU MVTT1, MVTT2 or ...
<p>Live vaccine but not killed vaccine controls bacterial loads following secondary challenge. Bacte...
<p>Ranking of efficacy on a range from − to +++ was based on weight loss and nasal colonization of m...
<p>Groups of mice co-treated with antibiotics (ATB) and MVATG18598 or MVATGN33.1 given thrice subcut...
<p>Number of relapsing mice (out of 6 infected) and day post-infection that relapses were observed a...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Mice were infected with 4–20 i.n. ECTV LD<sub>50</sub>. (A, B) CPGs treatments with or without VA...
<p>Mice were vaccinated and challenged as described in <a href="http://www.plosone.org/article/info:...